Devon nurse honoured with humanitarian medal by King
Devon nurse Paula Tobin has told of her pride at being presented with a Humanitarian Medal by King Charles for her life-saving work in Gaza.Ms Tobin, 57, from Tavistock, was awarded the honour in a ceremony at Buckingham Palace.She spent four months in Gaza, over three different deployments, volunteering for frontline medical charity UK-Med, and is due to return again in April.Ms Tobin said: "I found it much easier packing my bag to go out to Gaza than deciding what to wear to Buckingham Palace to meet the King."
Mum 'over the moon'
The field hospitals where she worked in Al Mawasi and Deir El Balah, established with Foreign, Commonwealth & Development Office (FCDO) funding, have treated more than 300,000 patients. "It is lovely to have my work recognised and my mum was absolutely over the moon when she heard the news," said Ms Tobin."Being able to take her to the palace hopefully goes a long way to making up for all the worry I've put her through over the years."A veteran of humanitarian crises including the West Africa Ebola outbreak in 2014, Ukraine and the Turkey earthquake, she said it was "hardest for your family back home"."Gaza's been a tough one because it is so much in the news," she said. "Each time I come back and I am okay, my family get a tiny bit more relaxed, but they do say 'just don't go again'. "I've told them I am returning in April and my response is always 'you know this is me, it's what I do. I'll be fine'."
Foreign Secretary David Lammy said the new medal "recognises the incredible dedication and selfless service of individuals on the frontline of the UK's responses to some of the world's most devastating crises"."I am delighted the first tranche of awards will recognise members of the UK government's emergency deployment teams, for their brave work in Libya, Morocco and Gaza," he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
44 minutes ago
- The Independent
NHS to receive £6bn to provide millions more tests and procedures, Reeves confirms
Rachel Reeves has pledged a £6bn investment aimed at accelerating tests and treatments within the NHS, following substantial year-on-year budget increases for the health service. The additional funding will facilitate new scanners, ambulances, and urgent treatment centres, with the goal of delivering up to four million more tests and procedures over the next five years. This announcement follows the chancellor's emphasis on NHS funding in her recent spending review, where she allocated an additional £29bn annually to the NHS budget. However, this increase comes at the expense of other areas of public spending. The £6bn boost is intended to support the Government's objective of reducing NHS waiting lists in England, according to the chancellor. 'Over a decade of underinvestment from the previous government put the NHS on its knees, with people across the country unable to get the care they need. We are investing in Britain's renewal, and we will turn that around,' Ms Reeves said. She added: 'Part of our record investment will deliver four million tests, scans and procedures, so hard-working people can get the healthcare they and their families need. 'There is no strong economy without a strong NHS, and we'll deliver on our Plan for Change to end the hospital backlog, improve living standards and get more money in people's pockets.' The latest spending commitment will help patients get access to diagnostic scans and treatment in places such as shopping centres and high streets, speeding up their diagnoses. The Government hopes this will help to cut NHS waiting lists, meeting Labour's goal of ensuring the health service carries out 92 per cent of routine operations within 18 weeks. Health Secretary Wes Streeting said: 'Since taking office we have been relentless in our drive to cut waiting times for patients, delivering over 3.6 million extra elective care appointments and reducing the overall waiting list by over 200,000. 'The £6bn investment we are announcing today will generate millions more vital diagnostic tests, scans and procedures for patients across the country.' On Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after giving the NHS a 3 per cent annual increase in funding at the spending review. Some health leaders are, however, sceptical that the Government will meet its target, despite the funding boost provided at the spending review. Matthew Taylor, chief executive of the NHS Confederation, which represents all health organisations, warned 'difficult decisions will still need to be made as this additional £29bn won't be enough to cover the increasing cost of new treatments, with staff pay likely to account for a large proportion of it'. He added: 'So, on its own, this won't guarantee that waiting time targets are met.' Sarah Woolnough, chief executive of the King's Fund charity, said: 'The chancellor said she wants the public to have an NHS there when they need it. 'It is hard to see how all the things she mentions: faster ambulance times, more GP appointments, and adequate mental health services and more can be met on this settlement alone. 'Particularly when large parts of this additional funding will be absorbed by existing rising costs, such as the higher cost of medicines, which are currently being negotiated, and covering staff pay deals.'
Daily Mail
an hour ago
- Daily Mail
UK Pharmaceutical industry at risk from government's 'sky-high' rebates system
The UK's status as a leader in medical research is at risk from 'sky-high and unpredictable' repayments pharmaceutical firms hand the Government, says an industry boss. Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry, said the rebate system – where firms repay money they make through selling medicines to the NHS – was sending 'a terrible message to international investors'. Rachel Reeves promised to support 'the UK's strengths in life sciences' and 'ensure patients get rapid access to the most clinically and cost-effective new technologies'. The Treasury plans to invest up to £520million in drug manufacturing in the next five years. Another £600million is earmarked for a health data research service to accelerate the discovery of new medicines. But Torbett said more was needed. 'Over the past decade, accounting for inflation, the NHS budget has grown by a third in real terms, while investment in the most rigorously cost-benefit-tested part of health spending – investment in the medicines needed to treat people – has fallen from around 11 per cent to 9 per cent of the health budget,' he added. And he attacked plans to increase what drug companies must repay from drug sales to 31.3 per cent, from 15.5 per cent. 'The sky-high and unpredictable payment rates send a terrible message to international investors when the UK is trying to position life sciences research and development as an engine for health and growth. For the sake of patients, the NHS and the economy, we need a commitment to bring these unsustainable rates down.'
The Independent
2 hours ago
- The Independent
The Inkey List's glycolic acid exfoliating stick worked magic on my keratosis pilaris
If you struggle with keratosis pilaris (also known as strawberry skin – a build-up of keratin within our skin pores) or sore razor bumps, then listen up. The much loved-affordable skincare brand The Inkey List may have produced the answer to our collective grumbles. Having sold out after its original launch, this stick claims to reduce the appearance of keratosis pilaris, razor bumps, hyper-pigmentation, breakouts and ingrown hairs. Results are promised after just one week, and drastic improvements are said to be visible after a month of consistent use. How does this miracle product work? Well, it's a combination of skin-loving hero ingredients. The glycolic acid is used to exfoliate the skin's surface and remove dead cells that leave the skin feeling rough, bumpy and uneven in tone. Salicylic acid helps to unclog oily pores, which is what causes issues like breakouts and ingrown hairs. Finally, shea butter offers a hydrating and moisturising effect. Chemical exfoliants have become the way of the future, and after testing this product, I'm beginning to see why. Here's how I got on with this miracle stick. How I tested Using the exfoliating stick every night for the last two months, I targeted keratosis pilaris on my arm, as well as underarm razor bumps and dry heels and elbows. I followed instructions carefully, starting by only using the stick two or three times a week and building up to every night once my skin had gotten used to it. To assess the product's efficacy, I looked for two things, appearance and texture. I noted any decrease in redness and improvement in brightness and paid close attention to any changes in the dryness or bumpiness of my skin.
